Search research articles
Contact Us
Filters
Showing results (271-280 of 281) with videos related to
Page
of 29
Sort By:
Postgraduate Medical Journal
|
June 24, 2024
Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA project
Carlos González-Muñoza, Margalida Calafat, Javier P Gisbert, et al.
Journal of Crohn'S & Colitis
|
February 1, 2022
Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU
Manuel Barreiro-de Acosta, Sabino Riestra, Margalida Calafat, et al.
Frontiers in Medicine
|
February 18, 2022
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients
Ana Gutiérrez, Pedro Zapater, Elena Ricart, et al.
The American Journal of Gastroenterology
|
December 14, 2022
Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU
Manuel Barreiro-de Acosta, Agnès Fernández-Clotet, Francisco Mesonero, et al.
Journal of Crohn'S & Colitis
|
August 1, 2022
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry
Diego Casas-Deza, Luis Javier Lamuela-Calvo, Fernando Gomollón, et al.
The American Journal of Gastroenterology
|
January 30, 2023
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
María Chaparro, Diana Acosta, Cristina Rodríguez, et al.
Alimentary Pharmacology & Therapeutics
|
August 8, 2025
Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA
Cristina Rubín de Célix, Elena Ricart, M Dolores Martín-Arranz, et al.
Journal of Clinical Medicine
|
January 21, 2022
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry
Yamile Zabana, Ignacio Marín-Jiménez, Iago Rodríguez-Lago, et al.
Journal of Clinical Medicine
|
December 23, 2022
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case-Control Study (COVID-19-EII)
Yamile Zabana, Ignacio Marín-Jiménez, Iago Rodríguez-Lago, et al.
Alimentary Pharmacology & Therapeutics
|
September 17, 2024
Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study
María Chaparro, Sandra Hermida, Diana Acosta, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 281) with videos related to
Sort By:
Page
of 29
Postgraduate Medical Journal
|
June 24, 2024
Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA project
Carlos González-Muñoza, Margalida Calafat, Javier P Gisbert, et al.
Journal of Crohn'S & Colitis
|
February 1, 2022
Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU
Manuel Barreiro-de Acosta, Sabino Riestra, Margalida Calafat, et al.
Frontiers in Medicine
|
February 18, 2022
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients
Ana Gutiérrez, Pedro Zapater, Elena Ricart, et al.
The American Journal of Gastroenterology
|
December 14, 2022
Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU
Manuel Barreiro-de Acosta, Agnès Fernández-Clotet, Francisco Mesonero, et al.
Journal of Crohn'S & Colitis
|
August 1, 2022
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry
Diego Casas-Deza, Luis Javier Lamuela-Calvo, Fernando Gomollón, et al.
The American Journal of Gastroenterology
|
January 30, 2023
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
María Chaparro, Diana Acosta, Cristina Rodríguez, et al.
Alimentary Pharmacology & Therapeutics
|
August 8, 2025
Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA
Cristina Rubín de Célix, Elena Ricart, M Dolores Martín-Arranz, et al.
Journal of Clinical Medicine
|
January 21, 2022
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry
Yamile Zabana, Ignacio Marín-Jiménez, Iago Rodríguez-Lago, et al.
Journal of Clinical Medicine
|
December 23, 2022
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case-Control Study (COVID-19-EII)
Yamile Zabana, Ignacio Marín-Jiménez, Iago Rodríguez-Lago, et al.
Alimentary Pharmacology & Therapeutics
|
September 17, 2024
Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study
María Chaparro, Sandra Hermida, Diana Acosta, et al.
Page
of 29